ANGELICA THERAPEUTICS INC has a total of 15 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are EMERGO THERAPEUTICS INC, YI QING and THERIMUNEX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | United Kingdom | 1 | |
#7 | Hong Kong | 1 | |
#8 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Davis Claude Geoffrey | 14 |
#2 | Datta Deepshikha | 14 |
#3 | Baker Matthew Paul | 12 |
#4 | Rust Alyson Jane | 12 |
#5 | Keen Simon | 12 |
#6 | Deepshikha Datta | 1 |
#7 | Alyson Jane Rust | 1 |
#8 | Simon Keen | 1 |
#9 | Matthew Paul Baker | 1 |
#10 | Claude Geoffrey Davis | 1 |
Publication | Filing date | Title |
---|---|---|
EP2968450A2 | Modified toxins | |
EP2268297A1 | Modified toxins | |
US2009010966A1 | Modified diphtheria toxins |